Research Article
The Expression and Clinical Significance of Different Forms of Mer Receptor Tyrosine Kinase in Systemic Lupus Erythematosus
Table 1
Clinical and laboratory characteristics in patients with SLE and healthy controls.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SLEDAI: systemic lupus erythematosus disease activity index; ANA: antinuclear antibody; Anti-dsDNA Ab: anti-double strand DNA Antibody; ACL: anticardiolipin antibody; AnuA: antinucleosome antibody; Sm: anti-Sm antibody; SSA: anti-SSA antibody; C3: Complement component 3; C4: Complement component 4. aValues are represented as either mean or number: (%). NA: not applicable. Numerical data were presented as mean ± SD and analyzed using the student’s -test or Pearson’s Chi-squared test. b as significant. |